WO2007107295A1 - Funktionelle lebensmittel gegen tumore - Google Patents
Funktionelle lebensmittel gegen tumore Download PDFInfo
- Publication number
- WO2007107295A1 WO2007107295A1 PCT/EP2007/002321 EP2007002321W WO2007107295A1 WO 2007107295 A1 WO2007107295 A1 WO 2007107295A1 EP 2007002321 W EP2007002321 W EP 2007002321W WO 2007107295 A1 WO2007107295 A1 WO 2007107295A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- products
- food composition
- milk
- use according
- carbohydrate source
- Prior art date
Links
- 235000013376 functional food Nutrition 0.000 title claims abstract description 31
- 230000000118 anti-neoplastic effect Effects 0.000 title 1
- 201000011510 cancer Diseases 0.000 claims abstract description 18
- 241001465754 Metazoa Species 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 10
- 230000002265 prevention Effects 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 83
- 235000013305 food Nutrition 0.000 claims description 62
- 230000002641 glycemic effect Effects 0.000 claims description 62
- 239000000047 product Substances 0.000 claims description 38
- 150000001720 carbohydrates Chemical class 0.000 claims description 33
- 235000014633 carbohydrates Nutrition 0.000 claims description 33
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 27
- 239000008103 glucose Substances 0.000 claims description 27
- 101000800498 Homo sapiens Transketolase-like protein 1 Proteins 0.000 claims description 18
- 102100033108 Transketolase-like protein 1 Human genes 0.000 claims description 15
- 235000005911 diet Nutrition 0.000 claims description 11
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 11
- 239000003925 fat Substances 0.000 claims description 11
- 235000013336 milk Nutrition 0.000 claims description 11
- 239000008267 milk Substances 0.000 claims description 11
- 210000004080 milk Anatomy 0.000 claims description 11
- 108010046377 Whey Proteins Proteins 0.000 claims description 10
- 102000007544 Whey Proteins Human genes 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 238000000855 fermentation Methods 0.000 claims description 10
- -1 monosaccharide alcohols Chemical class 0.000 claims description 10
- 235000019197 fats Nutrition 0.000 claims description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000006041 probiotic Substances 0.000 claims description 7
- 235000018291 probiotics Nutrition 0.000 claims description 7
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims description 6
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 6
- 239000005862 Whey Substances 0.000 claims description 6
- 235000008504 concentrate Nutrition 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 235000013406 prebiotics Nutrition 0.000 claims description 6
- 230000000529 probiotic effect Effects 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 5
- 230000004060 metabolic process Effects 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 150000005846 sugar alcohols Chemical class 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 4
- 229920000294 Resistant starch Polymers 0.000 claims description 4
- 244000299461 Theobroma cacao Species 0.000 claims description 4
- 235000015173 baked goods and baking mixes Nutrition 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 4
- 235000013736 caramel Nutrition 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 230000000378 dietary effect Effects 0.000 claims description 4
- 150000002016 disaccharides Chemical class 0.000 claims description 4
- 239000008298 dragée Substances 0.000 claims description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
- 229940029339 inulin Drugs 0.000 claims description 4
- 235000015110 jellies Nutrition 0.000 claims description 4
- 235000021243 milk fat Nutrition 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 235000021254 resistant starch Nutrition 0.000 claims description 4
- 235000021119 whey protein Nutrition 0.000 claims description 4
- SVBWNHOBPFJIRU-UHFFFAOYSA-N 1-O-alpha-D-Glucopyranosyl-D-fructose Natural products OC1C(O)C(O)C(CO)OC1OCC1(O)C(O)C(O)C(O)CO1 SVBWNHOBPFJIRU-UHFFFAOYSA-N 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- 229920000856 Amylose Polymers 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- 229920001100 Polydextrose Polymers 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims description 3
- 239000001259 polydextrose Substances 0.000 claims description 3
- 235000013856 polydextrose Nutrition 0.000 claims description 3
- 229940035035 polydextrose Drugs 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- NMXLJRHBJVMYPD-IPFGBZKGSA-N trehalulose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NMXLJRHBJVMYPD-IPFGBZKGSA-N 0.000 claims description 3
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 claims description 3
- 235000013618 yogurt Nutrition 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- DXALOGXSFLZLLN-WTZPKTTFSA-N (3s,4s,5r)-1,3,4,6-tetrahydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-one Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DXALOGXSFLZLLN-WTZPKTTFSA-N 0.000 claims description 2
- 241000195940 Bryophyta Species 0.000 claims description 2
- 235000021559 Fruit Juice Concentrate Nutrition 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- JPFGFRMPGVDDGE-UHFFFAOYSA-N Leucrose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)(CO)OC1 JPFGFRMPGVDDGE-UHFFFAOYSA-N 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 102000014171 Milk Proteins Human genes 0.000 claims description 2
- 108010011756 Milk Proteins Proteins 0.000 claims description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 235000008429 bread Nutrition 0.000 claims description 2
- 235000021152 breakfast Nutrition 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims description 2
- 235000015155 buttermilk Nutrition 0.000 claims description 2
- 229940071162 caseinate Drugs 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- 235000019219 chocolate Nutrition 0.000 claims description 2
- 235000020186 condensed milk Nutrition 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 235000015203 fruit juice Nutrition 0.000 claims description 2
- 235000020400 fruit nectar Nutrition 0.000 claims description 2
- 235000013569 fruit product Nutrition 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 235000011868 grain product Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 235000015141 kefir Nutrition 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 235000013310 margarine Nutrition 0.000 claims description 2
- 239000003264 margarine Substances 0.000 claims description 2
- 235000021239 milk protein Nutrition 0.000 claims description 2
- 150000002772 monosaccharides Chemical class 0.000 claims description 2
- 235000011929 mousse Nutrition 0.000 claims description 2
- 235000019520 non-alcoholic beverage Nutrition 0.000 claims description 2
- 235000015145 nougat Nutrition 0.000 claims description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 2
- 239000006014 omega-3 oil Substances 0.000 claims description 2
- 229940033080 omega-6 fatty acid Drugs 0.000 claims description 2
- 235000008476 powdered milk Nutrition 0.000 claims description 2
- 239000003531 protein hydrolysate Substances 0.000 claims description 2
- 235000011962 puddings Nutrition 0.000 claims description 2
- 238000004904 shortening Methods 0.000 claims description 2
- 235000021262 sour milk Nutrition 0.000 claims description 2
- 235000012773 waffles Nutrition 0.000 claims description 2
- 235000011845 white flour Nutrition 0.000 claims description 2
- 244000208874 Althaea officinalis Species 0.000 claims 1
- 235000006576 Althaea officinalis Nutrition 0.000 claims 1
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 235000012182 cereal bars Nutrition 0.000 claims 1
- 235000012495 crackers Nutrition 0.000 claims 1
- 235000011850 desserts Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000008157 edible vegetable oil Substances 0.000 claims 1
- 235000001035 marshmallow Nutrition 0.000 claims 1
- 235000014594 pastries Nutrition 0.000 claims 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 24
- 239000000306 component Substances 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 10
- 229930091371 Fructose Natural products 0.000 description 9
- 239000005715 Fructose Substances 0.000 description 9
- 210000004881 tumor cell Anatomy 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 235000003599 food sweetener Nutrition 0.000 description 8
- 239000003765 sweetening agent Substances 0.000 description 8
- 230000037213 diet Effects 0.000 description 7
- 239000000654 additive Substances 0.000 description 6
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 235000012041 food component Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000010439 isomalt Nutrition 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 150000003445 sucroses Chemical class 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000004376 Sucralose Substances 0.000 description 3
- 102000014701 Transketolase Human genes 0.000 description 3
- 108010043652 Transketolase Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000005417 food ingredient Substances 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 230000004153 glucose metabolism Effects 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 235000019408 sucralose Nutrition 0.000 description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical group COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 3
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 3
- 235000012141 vanillin Nutrition 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 235000008939 whole milk Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- 239000005428 food component Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 239000000905 isomalt Substances 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000001173 tumoral effect Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RJPPRBMGVWEZRR-WTZPKTTFSA-N (3s,4r,5r)-1,3,4,5-tetrahydroxy-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-one Chemical compound OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO)[C@H](O)[C@@H](O)[C@@H]1O RJPPRBMGVWEZRR-WTZPKTTFSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241001134770 Bifidobacterium animalis Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- GGLIEWRLXDLBBF-UHFFFAOYSA-N Dulcin Chemical compound CCOC1=CC=C(NC(N)=O)C=C1 GGLIEWRLXDLBBF-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001183 FEMA 4495 Substances 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108050004114 Monellin Proteins 0.000 description 1
- CWBZAESOUBENAP-QVNVHUMTSA-N Naringin dihydrochalcone Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C(O)C(C(=O)CCC=3C=CC(O)=CC=3)=C(O)C=2)O[C@H](CO)[C@@H](O)[C@@H]1O CWBZAESOUBENAP-QVNVHUMTSA-N 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001473878 Streptococcus infantarius Species 0.000 description 1
- 241000194046 Streptococcus intermedius Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 230000006682 Warburg effect Effects 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XLIJUKVKOIMPKW-BTVCFUMJSA-N [O].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O Chemical compound [O].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XLIJUKVKOIMPKW-BTVCFUMJSA-N 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 230000006536 aerobic glycolysis Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 235000019221 dark chocolate Nutrition 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000014168 granola/muesli bars Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000020887 ketogenic diet Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 235000020190 lactose-free milk Nutrition 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 239000000879 neohesperidine DC Substances 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000019722 synbiotics Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000019220 whole milk chocolate Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
- A23G1/40—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to the technical field of functional foods, namely novel functional foods for the treatment and / or prevention of malignant tumors of the human or animal body and methods for producing such functional foods.
- Nutrition and diseases are related. For example, it has long been known that adult onset diabetes (Type II diabetes) occurs primarily in individuals who ingest excessively carbohydrate-rich foods. There are also indications that the occurrence of certain cancers is directly related to certain dietary habits. For example, repeated and excessive intake of fructose in animal experiments (rats) leads to increased growth of chemically induced liver tumors (Enzmann H. et al. (1989) Carcinogenesis 10: 1247-1252). Fructose also appears to be associated with the onset of various cancers in humans (Michaud DS et al., (2002) J. Natl. Cancer Inst. 94: 1293-1300, Higginbotham H. et al (2004)). J. Natl.
- a ketogenic diet that is, a diet based on avoiding carbohydrate levels in the diet, positively influences disease progression in tumor diseases in single case studies (Nebeling LC et al., (1995) J. Am. Coli Nutr : 202-208).
- one-sided diets are known that completely dispense with a carbohydrate intake. Such diets avoid glucose-containing dietary constituents or those dietary constituents from which glucose can be enzymatically eliminated in the body.
- the energy metabolism of the majority of healthy body cells is usually based exclusively on the utilization (combustion or fermentation) of glucose.
- the brain of a human consumes about 25% of its total energy requirement, which can only be satisfied with glucose.
- glucose is missing in the diet, the body mobilizes glucose from the breakdown of storage fats (lipolysis), but also from the breakdown of vital and structuring proteins. The process is referred to as "ketogenesis", resulting in functional failures, coma and death.
- a low glycemic food composition that is, a food or a food component having a low glycemic index (GI) or a composition thereof, is used for producing a functional food serves to treat tumors of the human or animal body and / or to prevent malignant tumors.
- a low glycemic food composition that is, a food or a food component having a low glycemic index (GI) or a composition thereof, is used for producing a functional food serves to treat tumors of the human or animal body and / or to prevent malignant tumors.
- GI low glycemic index
- the invention provides, by use of a low glycemic food composition, to provide a functional food which has a low glycemic index. This ensures that the malignant tumor cells, which rely on aerobic glucose fermentation for their energy metabolism, no longer receive sufficient energy supply due to the lack of highly glycemic components. An occurrence of malignant tumor cells is thus prevented; Pre-existing malignant tumor cells are inhibited in their growth or die.
- a "low glycemic food composition” is understood to mean one or more foods or one or more food ingredients and compositions thereof, which comprises a low glycemic index (Gl).
- a low glycemic index is understood to mean a GI of 50 or less.
- the Gl is 40 or less, more preferably 30 or less, or 20 or less.
- the invention provides that the GI is not below a limit. That is, preferably, the low glycemic food composition comprises at least one glucose source, such as sucrose, maltose, starch / amylose, lactose, or glucose.
- the amount of Gl is at least 2 or more, at least 5 or more, or at least 10 or more.
- TKTL-1 transketolase-like 1
- TKTL-1 expression upregulation of TKTL-1 mRNA
- known aerobic glucose fermentation in healthy body cells is based on transketolase (TKT).
- the use according to the invention is particularly suitable for those patients in which at least one cell, ie in particular a malignant tumor cell, has an altered glucose metabolism which is based on an altered activity of the enzyme TKTL-1.
- suitable enzyme assays or by the detection of TKTL-1 expression, preferably at mRNA level, in body cells at- For example, as part of a clinical diagnostic examination, the patient collective can be determined which is particularly suitable for the treatment with the functional food according to the invention with a low glycemic food composition.
- the present invention relates to the use of a low glycemic food composition for the manufacture of a functional food for the treatment and / or prevention of malignant tumoral diseases of a human or animal body, which comprises at least one body cell having a change in the glucose compared to the normal state, especially an altered aerobic glucose fermentation metabolism.
- the normal state is defined by the fact that the cell, according to its physiological function and according to its tissue type, has the typical metabolic pathways for the production of energy from glucose. This means, above all, that in the normal state the body cell primarily breathes glucose while reacting with oxygen.
- the normal state of a cell may also be characterized by an aerobic glucose fermentation metabolism.
- Such cells are known, for example, from the retina or the testes. Such cells exhibit a transketolase activity in the normal state.
- an altered glucose metabolism in particular an altered aerobic glucose fermentation metabolism, is characterized in particular by the fact that the body cell has an activity or concentration of the enzyme transketolase-like 1 (TKTL-1) which is altered compared to the normal state.
- this also includes those cells which show altered enzyme activity in a TKTL-1 enzyme assay and / or have a modified content of the gene product in a manner known per se when TKTL-1 gene expression is determined, preferably at the mRNA level.
- the altered activity is understood as meaning increased enzyme activity.
- An altered content of the TKTL-1 gene product is preferably understood as meaning the occurrence of the TKTL-1 gene product in cells which in the normal state do not express or produce TKTL-1 and / or have an increased proportion of the TKTL-1 gene product.
- a low-glycemic food, food ingredient and / or food composition for producing a functional food used in the present invention preferably has at least one carbohydrate source selected from monosaccharides, disaccharides and polysaccharides as well as monosaccharide alcohols, disaccharide alcohols and polysaccharide alcohols.
- the low glycemic food composition has at least one low glycemic or non-glycemic carbohydrate source or component.
- the low glycemic food composition comprises, in addition to the at least one low glycemic or non-glycemic carbohydrate source or component, at least one (additional) high glycemic carbohydrate source or component.
- the low-glycemic food composition used according to the invention contains, preferably, only the sole carbohydrate source isomaltulose (6-O- ⁇ -D-glucopyranosyl-fructose, Palatinose®) in a proportion of 5 to 90% by weight, preferably in a proportion of 25 to 75 wt .-%, (based on total dry matter content).
- isomaltulose 6-O- ⁇ -D-glucopyranosyl-fructose, Palatinose®
- the low-glycemic food composition contains leucrosis, preferably the sole, carbohydrate source, preferably in an amount of from 5 to 90% by weight, preferably in an amount of from 25 to 75% by weight (based on total dry matter content).
- the low-glycemic food composition particularly preferably contains trehalulose, preferably the only carbohydrate source, in an amount of from 5 to 90% by weight, preferably in an amount of from 25 to 75% by weight, based on the total dry matter content.
- the low-glycemic food composition contains, as a single carbohydrate source, preferably turanose in a proportion of 5 to 90% by weight, preferably in a proportion of 25 to 75% by weight (based on total dry matter content).
- the low glycemic food composition contains resistant starch, preferably soluble starch, as preferred, sole carbohydrate source, preferably in a proportion of 5 to 90% by weight, preferably in a proportion of 25 to 75% by weight (based on total dry matter content ).
- resistant starch preferably soluble starch, as preferred, sole carbohydrate source, preferably in a proportion of 5 to 90% by weight, preferably in a proportion of 25 to 75% by weight (based on total dry matter content ).
- insoluble starch is provided.
- the low-glycemic food composition contains, as the sole, preferably carbohydrate source, polydextrose preferably in a proportion of 5 to 90% by weight, preferably in a proportion of 25 to 75% by weight (based on total dry matter content).
- the invention also relates to low glycemic food compositions wherein the low glycemic sucrose isomer is the only body sweetening agent present in the composition.
- the invention relates to an aforementioned composition, wherein the low glycemic sucrose isomer is the only sugar present in the mixture in the composition.
- the invention relates to an aforementioned composition, wherein the low glycemic sucrose isomer is the sole sweetening agent occurring in the composition in the composition.
- the low glycemic food composition contains as at least one sugar alcohol, preferably the sole, carbohydrate source selected from the group consisting of: isomalt, 1,1-GPM (1 -O- ⁇ -D-glucopyranosyl-D-mannitol), 1 , 6-GPS (6-O- ⁇ -D-glucopyranosyl-D-sorbitol), 1, 1 -GPS (1-0- ⁇ -D-glucopyranosyl-D-sorbitol), lactitol, maltitol, erythritol, xylitol, mannitol, sorbitol, maltitol syrup, hydrogenated and non-hydrogenated starch hydrolysates and a mixture of two or more thereof, preferably in a proportion of 5 to 90 wt .-%, preferably in an amount of 25 to 75 wt .-%, (based on total dry matter content).
- carbohydrate source selected from the group consisting of: iso
- the low glycemic food composition contains isomalt, preferably the sole carbohydrate source, a mixture of 1, 1-GPM and 1, 6-GPS, optionally with a proportion of 1, 1-GPS, preferably in a proportion of 5 to 90 wt .-%, preferably in an amount of 25 to 75 wt .-%, (based on total dry matter content).
- the low glycemic food composition contains as in, preferably the sole, carbohydrate source inulin in a proportion of 5 to 90 wt .-%, preferably in an amount of 25 to 75 wt .-%, (based on total dry matter content).
- the low-glycemic food composition contains ON, preferably single carbohydrate, ongofructose in a proportion of 5 to 90% by weight, preferably in a proportion of 25 to 75% by weight (based on the total dry matter content).
- the invention also relates to low glycemic food compositions, wherein the sugar alcohol is the only body-forming sweetening agent occurring in the composition.
- the invention relates to an aforesaid composition, wherein the sugar alcohol is the sole sweetening agent present in the composition in the composition.
- the low glycemic food composition contains fructose preferably, in a proportion of from 5 to 90% by weight, preferably in a proportion of from 25 to 75% by weight, based on the total dry matter content, as the, preferably sole, carbohydrate source.
- the low glycemic food composition contains at least 40% by weight (based on total dry matter content) of fructose as sole carbohydrate source.
- the invention also relates to low glycemic food compositions, wherein fructose is the only sugar occurring in the composition.
- the invention also relates to low glycemic food compositions, wherein fructose is the only body sweetening agent occurring in the composition.
- the invention relates to an aforementioned composition, wherein fructose is the only sweetening agent occurring in the mixture in the composition.
- the low-glycemic food composition used according to the invention nor the functional food produced are carbohydrate-free or low-carbohydrate. Rather, it is envisaged that the carbohydrate component contained is low in glycemic. It is therefore also envisaged that the low glycemic food composition contains at least one high glycemic component. Under a high glycemic component In the present case, a high glycemic glucose source is primarily understood, from which, in particular, enzymatic cleavage in the digestion and absorption process initially releases glucose into the organism.
- the high-glycemic component is preferably selected from glucose-yielding disaccharides, especially sucrose, maltose, lactose and trehalose, and maltodextrins, preferably resistant, soluble or insoluble, and starch / amylose and white flour products.
- the food composition contains at least one high glycemic carbohydrate source in addition to a low glycemic carbohydrate source.
- the low glycemic carbohydrate source and the high glycemic carbohydrate source are contained in the weight ratio 1: 1, 2: 1 or 1: 2.
- the low glycemic food composition contains the high glycemic carbohydrate source in an amount of 20% by weight or more, preferably 10% or more or 5% or more by weight, based on total dry matter content.
- the low glycemic food composition contains 10% by weight, preferably 5% by weight, more preferably 5% by weight (based on total dry matter content) or less glucose.
- the glycemic index of the low glycemic food composition is modified by at least one further component which reduces, delays or prevents the absorption and / or cleavage of glucose from food components in a manner known per se.
- Vorzugswei- se is such a component selected from proteins. Fats or thickeners.
- the low glycemic food composition contains at least 10, preferably at least 20, at least 30 or at least 40% by weight (based on total dry matter content) of a fat component selected from C8-C14 fatty acids, ⁇ -3 fatty acids, ⁇ - 6-fatty acids and polyunsaturated fatty acids.
- the low glycemic food composition contains at least 10, preferably at least 20, at least 30 or at least 40% by weight (based on total dry matter content) of a protein component.
- the low glycemic food composition contains at least one optional additive to be used.
- the use of the additives can be put together individually depending on the field of application and requirement profile of the markets and the consumers.
- a preferred additive is a prebiotic.
- the prebiotic advantageously positively influences the nutritional-physiological properties of the low-glycemic food composition or of the functional food obtainable therefrom.
- the prebiotic selectively stimulates the growth and / or the activity of probiotic microorganisms in the human or animal digestive tract, so that health-promoting effects occur.
- the prebiotic used is preferably inulin, oligofructose, resistant starch, ⁇ -glucans or galacto-oligosaccharides.
- Another preferred additive is a probiotic microorganism, a probiotic. In the present case, this is understood to mean a living microbial additional component which promotes its health by stabilizing or improving the microbial composition in the digestive tract of the human or animal consumer.
- Bifidobacterium such as strains B. adolescentis, B. animalis, B. bifidum, B. longum, B. thermophilum; Enterococccus; Lactobacillus such as the strains Lb. acidophilus, Lb.brevis, Lb, casei, Lb. cellobiosus, Lb. crispatus, Lb. delbrueckii subsp. Bulgaricus, Lb. fermentum, Lb. GG, Lb. johnsonii, Lb. lactis, Lb. plantarum, Lb. reuteri, Lb. rhamnosus, Lb.
- Bifidobacterium such as strains B. adolescentis, B. animalis, B. bifidum, B. longum, B. thermophilum
- Enterococccus Lactobacillus such as the strains Lb. acidophilus, Lb.brevis, Lb, casei
- probiotics are bacteria of the genera Lactobacillus and Bifidobacterium. Such probiotic bacterial cultures may preferably be embodied as dry cultures or permanent crops.
- Another preferred additive is a synbiotic.
- this is understood to mean a mixture of at least one prebiotic and at least one probiotic which promotes the health of the human or animal consumer by improving the survival rate and increasing the number of health-promoting living microbial organisms in the gastrointestinal tract, in particular by selectively stimulating the growth and / or the metabolic activity of microbial organisms.
- Another preferred additive is a dairy or dairy product, especially a lactose-free milk product.
- Preferred dairy or milk products are skimmed milk powder, whole milk powder, lactose-free skimmed or whole milk powder, whey extract or whey product. It is preferred that the low glycemic food composition contains the milk product in an amount of 2 to 40% by weight, preferably 5 to 20% by weight (based on the total weight).
- the low glycemic food composition contains at least one intensive sweetener, wherein the intensive sweetener is preferably selected from the group consisting of sucralose, sodium cyclamate, acesulfame K, neohesperidine dihydrochalcone, glycyrrhizin, stevenside, monellin, Thaumatin, aspartame, dulcine, saccharin, naringin dihydrochalcone, neotame and a mixture of two or more thereof.
- the intensive sweetener is preferably selected from the group consisting of sucralose, sodium cyclamate, acesulfame K, neohesperidine dihydrochalcone, glycyrrhizin, stevenside, monellin, Thaumatin, aspartame, dulcine, saccharin, naringin dihydrochalcone, neotame and a mixture of two or more thereof.
- the low-glycemic food composition contains at least one supplement or excipient which is preferably selected from the group consisting of: flavorings such as vanillin, colorants, flavorings, emulsifiers such as lecithin, thickeners such as pectin , Locust bean gum, guar gum, antioxidants, preservatives, minerals such as sodium or calcium, in particular salts such as sodium chloride, fiber, fibrous materials, triglycerides of medium chain lengths, phythoestrogens, natural or synthetic vitamins such as vitamin A, vitamin B 1 , vitamin B 2 , vitamin B 3 , Vitamin B 5 , Vitamin B 6 , Vitamin B 2 , Vitamin B complex, Vitamin C, Vitamin tamin D 1 Vitamin E, Vitamin F and Vitamin K, or combinations thereof.
- flavorings such as vanillin, colorants, flavorings, emulsifiers such as lecithin
- thickeners such as pectin , Locust bean gum, guar gum
- a supplement is understood to mean, in particular, those substances which affect the appearance, the taste, the organoleptic properties, the nutritional value, nutritional properties, the processability, storability or usefulness of the functional food produced.
- the functional food produced according to the invention is a pharmaceutical.
- the functional food that can be produced according to the invention is a dietary supplement.
- the functional food that can be produced according to the invention is a tube feed.
- the functional food produced according to the invention is a milk product or milk product, in particular a cheese, butter, yoghurt, kefir, quark, sour milk, buttermilk, cream, condensed milk, dried milk, whey, milk sugar, Milk protein, milk mix, milk semi-fat, whey mixed or milk fat product or preparation.
- a milk product or milk product in particular a cheese, butter, yoghurt, kefir, quark, sour milk, buttermilk, cream, condensed milk, dried milk, whey, milk sugar, Milk protein, milk mix, milk semi-fat, whey mixed or milk fat product or preparation.
- the functional food that can be produced according to the invention is a pudding, a cream, a mousse or another dessert or dessert product.
- the functional food produced according to the invention is a milk fat product, a mixed fat product, a edible fat or a cooking oil.
- the functional foodstuff which can be produced according to the invention is a bakery product, in particular selected from bread including biscuits and fine bakery products, long-life bakery products, cookie products and waffles.
- the functional food produced according to the invention is a spread, in particular selected from fatty spreads, margarine products and shortenings.
- the functional food that can be produced according to the invention is an instant product.
- the functional foodstuff which can be prepared according to the invention is a brewing product.
- the functional food produced according to the invention is a fruit product or a fruit preparation, in particular selected from jams, jams, jellies, fruit preserves, fruit pulp, fruit pulp, fruit juices, fruit juice concentrates, fruit nectar and fruit powder.
- the functional food produced according to the invention is a cereal product, in particular selected from cereal granola bars, cereal mixtures and breakfast products.
- the functional food produced according to the invention is a non-alcoholic beverage, beverage base or beverage powder.
- the functional foodstuff which can be prepared according to the invention is a, preferably dietetic, confectionery, in particular selected from chocolates, hard caramels, soft caramels, chewing gum, dragees, fondant products, jelly products, licorice, expanded sugar products, flakes, dragées, comprints , candied fruits, brittle, nougat products, ice cream confectionery, marzipan and ice cream.
- the functional food produced according to the invention is a sports and nutritional supplement, in particular selected from protein and amino acid concentrates, whey protein hydrolysates, isolates and concentrates, whey protein isolates and concentrates and caseinate preparations.
- a further subject matter of the present invention is the use of the above-characterized functional foodstuff preparable according to the invention for the treatment and / or treatment of malignant tumoral diseases of the human or animal body.
- Another object of the present invention is the use of a low glycemic food composition, food or food ingredient for the treatment and / or prevention of malignant tumors of the human or animal body.
- another object of the present invention is a method for the treatment and / or prevention of malignancies, the method comprising at least the step of: administering the above-characterized functional food or a low-glycemic food composition characterized above into the human or animal A body in a prophylactically and / or therapeutically active amount or dose, wherein the body has at least one body cell with an activity or concentration of the enzyme TKTL-1 which is altered compared to the normal state, in particular an increased activity or concentration.
- Lecithin e.g. 0.50
- Vanillin e.g. 0.02
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2007229060A AU2007229060A1 (en) | 2006-03-21 | 2007-03-16 | Functional foods against tumours |
JP2009500745A JP2009530326A (ja) | 2006-03-21 | 2007-03-16 | 腫瘍に対する機能性食品 |
EP07723303A EP1998633A1 (de) | 2006-03-21 | 2007-03-16 | Funktionelle lebensmittel gegen tumore |
US12/282,536 US20090221525A1 (en) | 2006-03-21 | 2007-03-16 | Functional foods against tumors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006014543.7 | 2006-03-21 | ||
DE102006014543A DE102006014543A1 (de) | 2006-03-21 | 2006-03-21 | Funktionelle Lebensmittel gegen Tumore |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007107295A1 true WO2007107295A1 (de) | 2007-09-27 |
Family
ID=38169457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/002321 WO2007107295A1 (de) | 2006-03-21 | 2007-03-16 | Funktionelle lebensmittel gegen tumore |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090221525A1 (de) |
EP (1) | EP1998633A1 (de) |
JP (1) | JP2009530326A (de) |
KR (1) | KR20090003289A (de) |
CN (1) | CN101404896A (de) |
AU (1) | AU2007229060A1 (de) |
DE (1) | DE102006014543A1 (de) |
WO (1) | WO2007107295A1 (de) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008055599A1 (en) * | 2006-11-09 | 2008-05-15 | Barry Callebaut Ag | Compositions |
WO2009095171A1 (de) * | 2008-01-31 | 2009-08-06 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Verfahren zur herstellung fermentierter getränke |
WO2010118866A1 (en) * | 2009-04-15 | 2010-10-21 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Trehalulose-containing composition, its preparation and use |
JP2011019402A (ja) * | 2009-07-13 | 2011-02-03 | Sharp Corp | 食材の組み合わせ方法と食品の組み合わせ方法 |
JP2011522548A (ja) * | 2008-06-11 | 2011-08-04 | ズートツッカー アクチェンゲゼルシャフト マンハイム/オクセンフルト | トレハルロースをベースとする高活性抗酸化剤 |
WO2013171424A1 (fr) * | 2012-05-16 | 2013-11-21 | Roquette Freres | Souche productrice de turanose et utilisations |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007026975A1 (de) * | 2007-06-01 | 2008-12-04 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Antioxidationsmittel für Lebensmittel |
DE102011008016A1 (de) * | 2011-01-06 | 2012-07-12 | Johannes F. Coy | Schokoladenmasse |
JP2016531114A (ja) * | 2013-07-31 | 2016-10-06 | 株式会社明治 | 腫瘍の成長を阻止する栄養組成物 |
KR102262008B1 (ko) * | 2018-06-28 | 2021-06-09 | 연세대학교 산학협력단 | 수크로오스를 유효성분으로 포함하는 항암용 조성물 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0185302A2 (de) * | 1984-12-19 | 1986-06-25 | PFEIFER & LANGEN | Süssungsmittel, Verfahren zur Herstellung und Verwendung desselben |
JPS637760A (ja) * | 1986-06-30 | 1988-01-13 | Lotte Co Ltd | 低齲蝕性飲食物の製造方法 |
DE3739999A1 (de) * | 1987-11-25 | 1989-07-06 | Suedzucker Ag | Verfahren zur herstellung von zuckerfreien, diaetetischen und/oder zahnschonenden schokoladen |
WO2000040101A1 (en) * | 1999-01-07 | 2000-07-13 | Danisco Cultor America, Inc. | Dietetic chocolate composition |
DE19943491A1 (de) * | 1999-09-10 | 2001-03-15 | Suedzucker Ag | Verbesserte Komprimate |
US20040052915A1 (en) * | 2002-09-13 | 2004-03-18 | Carlson Ting L. | Use of low glycemic index sweeteners in food and beverage compositions |
US6773743B1 (en) * | 2003-06-02 | 2004-08-10 | Michael Andrew Singer | Low carbohydrate sweetener |
EP1447013A1 (de) * | 2003-02-14 | 2004-08-18 | Wacker-Chemie GmbH | Methode zum Senken des glykämischen Index von Nahrungsmitteln |
WO2004068966A1 (en) * | 2003-02-08 | 2004-08-19 | Cerestar Holding B.V. | Process for preparing isomalto-oligosaccharides with elongated chain and low glycemic index |
US20040219141A1 (en) * | 2002-11-18 | 2004-11-04 | Shin Mitsui Sugar Co. Ltd. | Reducer of blood glucose level increase reducer of body fat accumulation and food material |
DE10349465A1 (de) * | 2003-10-23 | 2005-06-16 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Gelatinefreie, Isomaltulose-haltige Weichkaramelle |
US20050244910A1 (en) * | 2004-04-30 | 2005-11-03 | Wolever Thomas M | Methods for determining glycemic responses of foods |
DE202005015102U1 (de) * | 2005-09-23 | 2005-12-08 | VIVIL A. Müller GmbH & Co. KG | Kalorienreduzierte Gummibonbons |
WO2005115175A1 (en) * | 2004-05-28 | 2005-12-08 | Howard Foundation Holdings Limited | Food compositions containing creatine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2490037A1 (en) * | 2002-06-07 | 2003-12-18 | Alireza Haji Begli | Galactosyl isomalt, a method for producing it and its use |
DE10226203B4 (de) * | 2002-06-13 | 2008-04-03 | Südzucker AG Mannheim/Ochsenfurt | Kondensierte Palatinose, Verfahren zu deren Herstellung und deren Verwendung |
AU2003245156A1 (en) * | 2002-06-21 | 2004-01-06 | Canacure Corporation | Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof |
MXPA05013781A (es) * | 2003-06-16 | 2006-02-28 | Taiyo Kagaku Kk | Composicion y alimentos para disminuir el indice glicemico. |
DE10328180A1 (de) * | 2003-06-16 | 2005-01-13 | Südzucker AG Mannheim/Ochsenfurt | Verwendung von Isomalt als Präbiotikum |
-
2006
- 2006-03-21 DE DE102006014543A patent/DE102006014543A1/de not_active Withdrawn
-
2007
- 2007-03-16 US US12/282,536 patent/US20090221525A1/en not_active Abandoned
- 2007-03-16 JP JP2009500745A patent/JP2009530326A/ja active Pending
- 2007-03-16 CN CNA2007800102041A patent/CN101404896A/zh active Pending
- 2007-03-16 AU AU2007229060A patent/AU2007229060A1/en not_active Abandoned
- 2007-03-16 WO PCT/EP2007/002321 patent/WO2007107295A1/de active Application Filing
- 2007-03-16 KR KR1020087023911A patent/KR20090003289A/ko not_active Application Discontinuation
- 2007-03-16 EP EP07723303A patent/EP1998633A1/de not_active Withdrawn
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0185302A2 (de) * | 1984-12-19 | 1986-06-25 | PFEIFER & LANGEN | Süssungsmittel, Verfahren zur Herstellung und Verwendung desselben |
JPS637760A (ja) * | 1986-06-30 | 1988-01-13 | Lotte Co Ltd | 低齲蝕性飲食物の製造方法 |
DE3739999A1 (de) * | 1987-11-25 | 1989-07-06 | Suedzucker Ag | Verfahren zur herstellung von zuckerfreien, diaetetischen und/oder zahnschonenden schokoladen |
WO2000040101A1 (en) * | 1999-01-07 | 2000-07-13 | Danisco Cultor America, Inc. | Dietetic chocolate composition |
DE19943491A1 (de) * | 1999-09-10 | 2001-03-15 | Suedzucker Ag | Verbesserte Komprimate |
US20040052915A1 (en) * | 2002-09-13 | 2004-03-18 | Carlson Ting L. | Use of low glycemic index sweeteners in food and beverage compositions |
US20040219141A1 (en) * | 2002-11-18 | 2004-11-04 | Shin Mitsui Sugar Co. Ltd. | Reducer of blood glucose level increase reducer of body fat accumulation and food material |
WO2004068966A1 (en) * | 2003-02-08 | 2004-08-19 | Cerestar Holding B.V. | Process for preparing isomalto-oligosaccharides with elongated chain and low glycemic index |
EP1447013A1 (de) * | 2003-02-14 | 2004-08-18 | Wacker-Chemie GmbH | Methode zum Senken des glykämischen Index von Nahrungsmitteln |
US6773743B1 (en) * | 2003-06-02 | 2004-08-10 | Michael Andrew Singer | Low carbohydrate sweetener |
DE10349465A1 (de) * | 2003-10-23 | 2005-06-16 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Gelatinefreie, Isomaltulose-haltige Weichkaramelle |
US20050244910A1 (en) * | 2004-04-30 | 2005-11-03 | Wolever Thomas M | Methods for determining glycemic responses of foods |
WO2005115175A1 (en) * | 2004-05-28 | 2005-12-08 | Howard Foundation Holdings Limited | Food compositions containing creatine |
DE202005015102U1 (de) * | 2005-09-23 | 2005-12-08 | VIVIL A. Müller GmbH & Co. KG | Kalorienreduzierte Gummibonbons |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 198808, Derwent World Patents Index; AN 1988-052552, XP002439606 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008055599A1 (en) * | 2006-11-09 | 2008-05-15 | Barry Callebaut Ag | Compositions |
EA017724B1 (ru) * | 2008-01-31 | 2013-02-28 | Зюдцукер Акциенгезелльшафт Маннхайм/Окзенфурт | Способ получения сладкого ферментированного напитка |
WO2009095171A1 (de) * | 2008-01-31 | 2009-08-06 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Verfahren zur herstellung fermentierter getränke |
US10194679B2 (en) | 2008-01-31 | 2019-02-05 | Sudzucker Aktiengesellschaft | Process for the production of fermented beverages |
JP2011522548A (ja) * | 2008-06-11 | 2011-08-04 | ズートツッカー アクチェンゲゼルシャフト マンハイム/オクセンフルト | トレハルロースをベースとする高活性抗酸化剤 |
US9744184B2 (en) | 2009-04-15 | 2017-08-29 | Sudzucker Aktiengesellschaft Mannheim/Ochsenfurt | Trehalulose-containing composition, its preparation and use |
JP2012523825A (ja) * | 2009-04-15 | 2012-10-11 | ズートツッカー アクチェンゲゼルシャフト マンハイム/オクセンフルト | トレハルロース含有組成物、その調製及びその使用 |
JP2015109841A (ja) * | 2009-04-15 | 2015-06-18 | ズートツッカー アクチェンゲゼルシャフト マンハイム/オクセンフルト | トレハルロース含有組成物、その調製及びその使用 |
US9707249B2 (en) | 2009-04-15 | 2017-07-18 | Sudzucker Aktiengesellschaft Mannheim/Ochsenfurt | Trehalulose-containing composition, its preparation and use |
EP2418971B1 (de) * | 2009-04-15 | 2017-09-06 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Trehalulose enthaltende zusammensetzung, ihre herstellung und verwendung |
EA029353B1 (ru) * | 2009-04-15 | 2018-03-30 | Зюдцукер Акциенгезелльшафт Маннхайм/Окзенфурт | Содержащая трегалулозу композиция, ее получение и применение |
WO2010118866A1 (en) * | 2009-04-15 | 2010-10-21 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Trehalulose-containing composition, its preparation and use |
JP2011019402A (ja) * | 2009-07-13 | 2011-02-03 | Sharp Corp | 食材の組み合わせ方法と食品の組み合わせ方法 |
WO2013171424A1 (fr) * | 2012-05-16 | 2013-11-21 | Roquette Freres | Souche productrice de turanose et utilisations |
FR2990696A1 (fr) * | 2012-05-16 | 2013-11-22 | Roquette Freres | Souche productrice de turanose et utilisations |
US9382562B2 (en) | 2012-05-16 | 2016-07-05 | Roquette Freres | Strains of Serratia plymuthica producing turanose and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20090003289A (ko) | 2009-01-09 |
CN101404896A (zh) | 2009-04-08 |
US20090221525A1 (en) | 2009-09-03 |
DE102006014543A1 (de) | 2007-09-27 |
EP1998633A1 (de) | 2008-12-10 |
AU2007229060A1 (en) | 2007-09-27 |
JP2009530326A (ja) | 2009-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1513942B1 (de) | Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung | |
WO2007107295A1 (de) | Funktionelle lebensmittel gegen tumore | |
JP4451879B2 (ja) | イソマルトのプレバイオティクスとしての使用 | |
US6544568B2 (en) | Symbiotic functional food containing lactic acid bacteria | |
EP2387322B1 (de) | Stabilitätsverbesserte schokoladenzusammensetzungen auf reisstärkebasis | |
DE10262018B4 (de) | Zusammensetzungen, Nahrungs-, Lebens-, und Genussmittel, Süßwaren, Tierfuttermittel, diätische Spezial-Ernährung, Kinderernährung, Süßungsmittel und pharmazeutische Zusammensetzungen enthaltend kondensierte Palatinose | |
DE102007009029A1 (de) | Niedrig-glykämische Mischungen | |
IL165448A (en) | Galactosyl isomalt compositions and methods for producing galactosyl isomalt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07723303 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007723303 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007229060 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2007229060 Country of ref document: AU Date of ref document: 20070316 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009500745 Country of ref document: JP Ref document number: 200780010204.1 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087023911 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12282536 Country of ref document: US |